Paul Tudor Jones Quanterix Corp Transaction History

Tudor Investment Corp Et Al

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 15, 2023	SELL	$21.15 - $27.96 $380,467 - $502,972	-17,989 Reduced 44.75%	22,214 $602,000
Q2 2023 Aug 14, 2023	SELL	$11.16 - $23.65 $582,607 - $1.23 Million	-52,205 Reduced 56.49%	40,203 $906,000
Q1 2023 May 15, 2023	BUY	$10.12 - $14.91 $129,485 - $190,773	12,795 Added 16.07%	92,408 $1.04 Million
Q4 2022 Feb 14, 2023	SELL	$8.75 - $14.02 $110,818 - $177,563	-12,665 Reduced 13.72%	79,613 $1.1 Million
Q3 2022 Nov 14, 2022	BUY	$7.46 - $19.28 $407,965 - $1.05 Million	54,687 Added 145.48%	92,278 $1.02 Million
Q2 2022 Aug 15, 2022	BUY	$15.06 - $30.65 $389,436 - $792,578	25,859 Added 220.41%	37,591 $609,000
Q1 2022 May 16, 2022	BUY	$23.26 - $42.41 $272,886 - $497,554	11,732 New	11,732 $342,000
Q2 2021 Aug 16, 2021	SELL	$43.3 - $67.17 $1.26 Million - $1.96 Million	-29,162 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$44.11 - $90.64 $1.29 Million - $2.64 Million	29,162 New	29,162 $1.71 Million

155

33.2M

30.6K

25.1K

Ticker QTRX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 36,987,600
Market Cap $436M
Description
Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detecti...

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.